Glenmark Pharmaceuticals
May 16, 2012 at 12:24 | Source: Moneycontrol.com
May 16, 2012 at 12:12 | Source: Moneycontrol.com
May 12, 2012 at 13:51 | Source: Moneycontrol.com
May 11, 2012 at 10:08 | Source: CNBC-TV18
May 10, 2012 at 15:00 | Source: Moneycontrol.com
May 10, 2012 at 13:52 | Source: Moneycontrol.com
News across the web »
May 25, 2012 at 02:06 | Source: Business Standard
May 24, 2012 at 03:16 | Source: Business Standard
May 24, 2012 at 01:01 | Source: Business Standard
May 21, 2012 at 14:22 | Source: Economic Times
May 19, 2012 at 12:11 | Source: Economic Times
Interact & exchange stock tips & market info »
Related News »
As per ORG IMS MAT March 2012 data, Glenmark has gained two rank, from 25th to 23rd. Further, its market share has increased in dermatology from 8.3% to 8.4%, cardiology 2.4% to 2.5% and respiratory from 1.2% to 2.7%. Glenmark Pharma has ...
May 25, 2012 at 15:13 | Source: equitybulls.com
Glenmark Pharmaceuticals is set to enter the final stage of clinical trials for its new drug, Revamilast, across several countries this year. It is meant for treatment of inflammatory disorders like asthma and rheumatoid arthritis. Glenmark may soon seek ...
May 24, 2012 at 19:39 | Source: Business Standard
New Delhi, May 16 (PTI) Glenmark Pharmaceuticals today said it has received tentative approval from the US health regulator for generic Zolmitriptan tablets used for treating migraines. Glenmark Generics Inc, the US arm of Glenmark Generic has received ...
May 16, 2012 at 12:32 | Source: MSN India
Glenmark Pharmaceuticals is set to enter the final stage of clinical trials for its new drug, Revamilast, across several countries this year. It is meant for treatment of inflammatory disorders like asthma and rheumatoid arthritis. Glenmark may soon seek ...
May 24, 2012 at 19:32 | Source: Business Standard
(RTTNews) - Glenmark Pharmaceuticals Ltd. said its US subsidiary Glenmark Generics Inc. has obtained tentative approval from US FDA for Zolmitriptan orally disintegrating tablets, its generic version of AstraZeneca's Zomig-ZMT tablets. The tentative ...
May 16, 2012 at 06:56 | Source: RTT News
Among frontline companies, all acute focused companies, including Glenmark Pharmaceuticals Ltd, Pfizer Ltd and GlaxoSmithKline Pharmaceuticals Ltd, significantly outperformed the industry because of strong recovery in segments such as anti-infective ...
May 23, 2012 at 17:17 | Source: Livemint.com
The Glenmark Pharmaceuticals Ltd stock was trading at Rs.356.25, down by Rs.9.10 or 2.49%. The stock hit an intraday high of Rs.369.70 and low of Rs.352.65. The total traded quantity was 0.81 lakhs compared to 2 week average of 1.53 lakhs.
May 16, 2012 at 07:17 | Source: equitybulls.com
has granted tentative approval for Glenmark Generics Inc's (GGI), a US based subsidiary of Glenmark Pharmaceuticals Ltd, zolmitriptan orally disintegrating tablets, the generic version of AstraZeneca's Zomig-ZMT tablets. The tentative approval is for the 2 ...
May 16, 2012 at 07:46 | Source: pharmabiz.com
After beating street expectations in the fourth quarter, Glenmark Pharmaceuticals expects to continue strong growth momentum this year too. It expects sales will rise 22-25% (excluding licensing income), helped by new drug launches in the US ...
May 9, 2012 at 06:28 | Source: MoneyControl.com
(Business Standard) * Glenmark Pharmaceuticals is set to enter the final stage of clinical trials for its new drug, Revamilast, across several countries this year. (Business Standard) RETAIL Malaysia-based private equity Navis Capital Partners ...
May 25, 2012 at 03:18 | Source: Reuters